Testing the effects of the Strong Together self-advocacy serious game among women with advanced cancer: Protocol for the STRONG randomized clinical trial

Contemp Clin Trials. 2023 Jan:124:107003. doi: 10.1016/j.cct.2022.107003. Epub 2022 Nov 13.

Abstract

Background: Women with advanced cancer experience significant barriers to achieving high-quality care and maximizing their physical and emotional health. Our novel serious game, Strong Together, aims to teach women with advanced cancer self-advocacy skills needed to improve their symptom burden, quality of life, and patient-centered care.

Methods: This is a single-center, multi-site randomized clinical trial of the Strong Together intervention among 336 women within three months of an advanced breast or gynecologic cancer diagnosis. Randomization occurs to the 3-month Strong Together serious game or enhanced care as usual group. The aims are to: (1) evaluate the effects of the intervention on patient self-advocacy (primary outcome); (2) evaluate the effects of the intervention on quality of life, symptom burden, and patient-centered care (secondary outcomes); and (3) evaluate the behavioral and game mechanisms that influence the efficacy of the intervention.

Eligibility criteria: female, age ≥ 18 years; diagnosis of advanced breast or gynecologic cancer within the past 3 months; Eastern Cooperative Oncology Group score of 0-2; English literacy; and ≥ 6-month life expectancy. Patient-reported outcome measures are collected at baseline, 3-months, and 6-months.

Conclusion: This protocol is the first large-scale intervention aimed at promoting self-advocacy in women with advanced cancer. Understanding the ability of serious games to impact patient outcomes provides critical information for researchers, clinicians, and stakeholders aiming to improve patient-centered care.

Trial registration: NCT04813276.

Keywords: Communication; Decision-making; Health games; Patient self-advocacy; Videogames; Virtual systems.

Publication types

  • Clinical Trial Protocol
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Breast Neoplasms* / pathology
  • Breast Neoplasms* / therapy
  • Female
  • Games, Experimental*
  • Genital Neoplasms, Female* / pathology
  • Genital Neoplasms, Female* / therapy
  • Humans
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Self Care*
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT04813276